Content about Eli Lilly

February 9, 2012
NAFE names its 'Top 50 Companies for Executive Women'

The National Association for Female Executives on Wednesday released its list of the "Top 50 Companies for Executive Women."

February 1, 2012
Lilly Diabetes donates diabetes camp scholarships

Through a collaboration with the American Diabetes Association, the diabetes division of drug maker Eli Lilly has committed to send 89 children to diabetes camp this summer.

January 31, 2012
FDA approves Lilly-Boehringer Ingelheim diabetes drug

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

January 11, 2012
Amylin outlines diabetes strategy for 2012

A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

December 9, 2011
Lilly expands Spanish-language section of 'Lilly for Better Health' Web portal

Drug maker Eli Lilly has expanded its Spanish-language portal, the company said Friday.

December 1, 2011
Lilly study to determine why many diabetes patients don't reach blood-glucose goals

Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

November 17, 2011
Lilly donates $4 million for tuberculosis drug discovery

Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

November 8, 2011
Lilly, Amylin terminate diabetes alliance

Eli Lilly and Amylin Pharmaceuticals are ending their diabetes-drug alliance, the two companies said Tuesday.

October 25, 2011
Lilly removes Xigris from market

Eli Lilly is withdrawing one of its drugs from the market after clinical trials showed it to be ineffective.

October 24, 2011
FDA approves generic versions of Zyprexa

The Food and Drug Administration has approved the first generic versions of two drugs made by Eli Lilly for treating schizophrenia and bipolar disorder, the agency said Monday.

October 20, 2011
Byetta approved for use with Lantus

A diabetes drug made by Eli Lilly and Amylin Pharmaceuticals has received approval from the Food and Drug Administration for use with an insulin product made by Sanofi.

October 20, 2011
Prasco to market authorized generic Zyprexa

Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

October 11, 2011
Lilly announces senior management changes

Two senior leaders at Eli Lilly are retiring, the company said Tuesday.

October 7, 2011
Lilly's Cialis approved for benign prostatic hyperplasia

The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday.

September 27, 2011
Study: Lilly drug keeps common lung cancer under control in elderly patients

A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

September 21, 2011
UCLA researchers find possible link between diabetes drugs, pancreatic cancer

Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

September 16, 2011
BI, Lilly drug reduces blood sugar over long term

A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.

September 15, 2011
Lilly invests in partnership to fight NCDs

Drug maker Eli Lilly is investing $30 million in a partnership that will address noncommunicable diseases, also known as chronic diseases.

September 8, 2011
Boehringer Ingelheim, Eli Lilly present data from studies of diabetes drugs

Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

September 8, 2011
Lilly expands multimedia efforts with YouTube channel

A few months after launching its multichannel platform to inform and educate patients about healthy eating, physical activity and stress management, drug maker Eli Lilly has debuted a new YouTube channel.

August 17, 2011
American Diabetes Association, Lilly team for annual Victory Over Diabetes event

The American Diabetes Association, with help from drug maker Eli Lilly, once again is hosting a free communitywide event in Atlanta that's designed to educate African-Americans on diabetes management.

August 16, 2011
Study: Effient reduces cardiovascular risk among younger, heavier patient cohort

A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

August 11, 2011
FDA sets review date for Bydureon

The Food and Drug Administration has acknowledged the resubmission of an investigational Type 2 diabetes drug made by Amylin Pharmaceuticals, Eli Lilly and Alkermes.

August 1, 2011
Federal court upholds Lilly patent

A federal court has upheld Eli Lilly's patent covering a drug used to treat attention deficit hyperactivity disorder, Lilly said Friday.

August 1, 2011
Lilly, Lupin enter diabetes partnership

Eli Lilly’s India division and Indian generic drug maker Lupin will distribute Lilly’s insulin products in India and Nepal under an agreement between the two companies announced Friday.

© 2013 Drug Store News. All Rights Reserved.